The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report.
Journal Information
Full Title: Naunyn Schmiedebergs Arch Pharmacol
Abbreviation: Naunyn Schmiedebergs Arch Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Competing interestsThe authors declare no competing interests. Ethical approvalReview article/non-applicable. Conflict of interestAF, MR, and AS declare that they have no competing interests. PS and JRK are full-time employees of Bayer AG, Pharmaceuticals. Competing interests The authors declare no competing interests. Conflict of interest AF, MR, and AS declare that they have no competing interests. PS and JRK are full-time employees of Bayer AG, Pharmaceuticals."
"Funding The 10th cGMP meeting 2022 was financially supported by the Platin Sponsors, the Deutsche Forschungsgemeinschaft (DFG), Bayer AG, and Merck Sharp & Dohme Corp (MSD); the Gold Sponsor, Cyclerion; and the Corporate Sponsors, Bio Log, DSI, Biomol, Eppendorf, and Zeiss. Research related on cGMP signaling in the labs of AF, MR and AS are funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation – FR 1725/3-2, RU 1413/2-1 and SCHM 2629/4-1). "
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025